The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men-Reference-Cited by-同舟云学术

The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men

Published:2014-12 Issue:6 Volume:66 Page:1109-1115
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Vedder Moniek M.,de Bekker-Grob Esther W.,Lilja Hans G.,Vickers Andrew J.,van Leenders Geert J.L.H.,Steyerberg Ewout W.,Roobol Monique J.

Publisher

Elsevier BV

Subject

Urology

Reference32 articles.

1. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease;Heidenreich;Eur Urol,2011

2. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer;Draisma;J Natl Cancer Inst,2003

3. Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer;Heijnsdijk;Br J Cancer,2009

4. Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram;Steyerberg;J Urol,2007

5. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial;Thompson;J Natl Cancer Inst,2006

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial;European Urology;2024-09

2. Different diagnostic strategies combining prostate health index and magnetic resonance imaging for predicting prostate cancer: A multicentre study;Urologic Oncology: Seminars and Original Investigations;2024-05

3. How to Integrate Prostate Cancer Biomarkers in Urology Clinical Practice: An Update;Cancers;2024-01-11

4. Liquid Biomarkers in Prostate Cancer Diagnosis: Current Status and Emerging Prospects;The World Journal of Men's Health;2024

5. A novel approach to PAAD patient care: A 9-cuproptosis-related differential expression lncRNAs model for prognosis prediction;2023-03-23